Robert Whitfield MDAmerica's Breast Implant Illness Expert™

PCR, Bacterial Contamination & a BII Biomarker | Dr. Rob Whitfield #Shorts

8 Jul 2026 · 1 min

Watch on YouTube

1:23

In this short presentation Dr. Robert Whitfield explains that, beginning in 2019, his team has sent all explanted scar tissue specimens for polymerase chain reaction (PCR) testing because PCR offers higher sensitivity and specificity for detecting bacteria. Their published series— the largest of its kind—found that 29% of these specimens showed bacterial contamination, establishing that bacterial presence on implants is a real, measurable phenomenon. Whitfield argues that bacteria entering the bloodstream can adhere to any foreign implant (hip, knee, breast, dental, cardiac, neurologic, etc.) and persist because the body cannot clear them. On breast implants, these bacteria interact with the surrounding fatty tissue, specifically oxidizing the fatty acid oleic acid. This oxidation increases oxidative stress, pushes the local environment toward a more oxidized state, and triggers downstream immune changes, notably altering macrophage activity. The resulting cascade produces a detectable biomarker in research settings, which correlates with the symptoms reported by patients with breast implant illness (BII). The overall claim is that bacterial colonization and the consequent oleic acid oxidation represent a mechanistic pathway underlying BII, and that the biomarker provides objective evidence of this process.

Chapters

So since 2019, we've sent all of our scar tissue specimens off for PCR analysis because we know it's more sensitive and it's more specific. And we published the largest series in the world looking at scar tissue specimens after explant, and 29% have bacterial contamination. So that's a real thing. You can't dispute that. That's what it is. Yeah. So what does that mean? That means Throughout the course of life, we got bacteria in our blood, and if we had an implant, whether it's a hip, knee, breast, dental, cardiac, neurologic, whatever, that stuff can get stuck on there because our body can't take care of it because that's not our body. Yeah. And then that stuff can sit there on the breast implant in this case and signal back and forth to the breast tissue. Now, specifically in the breast tissue, there's a fatty acid oleic acid. It can get oxidized. Now, we don't want too much oxidative stress because that's harder for our bodies. We want to live in a more reduced state. So this causes more oxidative stress, and it oxidizes the oleic acid that goes downstream in our immune system and ultimately causes activation and changes in macrophages. Long story short is that's responsible for symptoms when you measure it in a research environment in patients with breast implant illness. So that's a real biomarker.